Atlas Trials

Ascendis Pharma Endocrinology Division A/S

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Ascendis Pharma Endocrinology Division A/S

RecordFirmDate
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin (NCT05775523)Ascendis Pharma Endocrinology Division A/S2023-03-20
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA (NCT05820672)Ascendis Pharma Endocrinology Division A/S2023-03-20
A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome (NCT05690386)Ascendis Pharma Endocrinology Division A/S2023-02-15
A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency (NCT05171855)Ascendis Pharma Endocrinology Division A/S2021-12-16
A Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency (NCT04615273)Ascendis Pharma Endocrinology Division A/S2020-12-03
A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency (NCT03305016)Ascendis Pharma Endocrinology Division A/S2017-11-13
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) (NCT02781727)Ascendis Pharma Endocrinology Division A/S2016-12-13

Track Ascendis Pharma Endocrinology Division A/S automatically

Every clearance here is in the API, with alerts when new ones post.